Confocal Scanning Laser Tomography Analysis of Choroidal Neovascularization and Correlation with Quantitative Fluorescein Angiography

REFERENCES

• Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. One-year results of two randomized clinical trials—TAP Report 1. Arch Ophthalmol 1999; 117: 1329–1345
   PubMed Web of Science ®Google Scholar
• Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of two randomized clinical trials—TAP Report 2. Arch Ophthalmol 2001; 119: 198–207
   PubMed Web of Science ®Google Scholar
• Verteporfin in Photodynamic Therapy [VIP] Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. One-year results of a randomized clinical trial—VIP Report 1. Ophthalmology 2001; 108: 841–852
   PubMedGoogle Scholar
• Krebs I, Binder S, Stolba U, Glittenberg C, Brannath W, Goll A. Choroidal neovascularization in pathologic myopia: Three-year results after photodynamic therapy. Am J Ophthalmol 2005; 140: 416–425
   PubMedGoogle Scholar
• Verteporfin in Photodynamic Therapy [VIP] Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial, including lesions with occult with no classic choroidal neovascularization—VIP Report 2. Am J Ophthalmol 2001; 131: 541–560
   PubMedGoogle Scholar
• Sickenberg M, Ballini J P, van den Bergh H. A computer-based method to quantify the classic pattern of choroidal neovascularization in order to monitor photodynamic therapy. Graefe's Arch Clin Exp Ophthalmol 1999; 237: 353–360
   PubMedGoogle Scholar
• Shah S M, Tatlipinar S, Quinlan, Sung J U, Tabandeh H, Nguyen Q D, et al. Dynamic and quantitative analysis of choroidal neovascularization by fluorescein angiography. Invest Ophthalmol Vis Sci 2006; 47: 5460–5468
   PubMedGoogle Scholar
• Chakravarthy U, Walsh A C, Muldrew A, Updike P G, Barbour T, Sadda S R. Quantitative fluorescein angiographic analysis of choroidal neovascular membranes: Validation and correlation with visual function. Invest Ophthalmol Vis Sci 2007; 48: 349–354
   PubMedGoogle Scholar
• Gass J DM. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment, 4th ed. Mosby, St. Louis, MO 1997; vol. 1
   Google Scholar
• Marco Z, Bernard S. Current treatment of age related macular degeneration. Opt Vis Sci 2007; 84: 559–572
   PubMedGoogle Scholar
• Bressler N M, Bressler S B, Fine S L. Age related macular degeneration. Surv Ophthalmol 1988; 32: 375–413
   PubMed Web of Science ®Google Scholar
• Hudson C, Flanagan J G, Turner G S, McLeod D. Scanning laser tomography Z profile signal width as an objective index of macular retinal thickening. Br J Ophthalmol 1988; 82: 121–130
   Google Scholar
• Pallikaris A, Skondra D, Tsilimbaris M. Intra-observer repeatability of confocal scanning laser ophthalmoscopy in normal, diabetic, and CNV patients. Am J Ophthalmol 2005; 139: 624–630
   PubMed Web of Science ®Google Scholar
• Kisilevsky M, Hudson C, Flanagan J G, Nrusimhadevara R K, Guan K, Wong T, et al. Agreement of the Heidelberg Retina Tomograph II Macula Edema Module with fundus biomicroscopy in diabetic maculopathy. Arc Ophthalmol 2006; 124: 337–342
   PubMedGoogle Scholar
• Degenring R F, Aschmoneit I, Kamppeter V, Budde W M, Jonas J B. Optical coherence tomography and confocal scanning laser tomography for assessment of macular edema. Am J Ophthalmol 2004; 138: 354–361
   PubMed Web of Science ®Google Scholar
• Guan K, Hudson C, Flanagan J G. Comparison of Heidelberg retina tomography II and retinal thickness analyzer in the assessment of diabetic macular edema. Invest Ophthalmol Vis Sci 2004; 45: 610–616
   PubMed Web of Science ®Google Scholar
• Jaakkola A, Vesti E, Immonen I. The use of confocal scanning laser tomography in the evaluation of retinal elevation in age-related macular degeneration. Ophthalmology 1999; 106: 274–279
   PubMedGoogle Scholar
• Hudson C, Flanagan J G, Turner G S, Chen H C, Young L B, McLeod D. Correlation of a scanning laser derived oedema index and visual function following laser treatment for diabetic macular oedema. Br J Ophthalmol 2003; 87: 455–461
   PubMedGoogle Scholar
• Holladay J T. Visual acuity measurements. J Cataract Refract Surg 2004; 30: 287–290
   PubMed Web of Science ®Google Scholar
• Cree M J, Olson J A, McHardy K C, Sharp P F, Forrester J V. The preprocessing of retinal images for the detection of fluorescein leakage. Phys Med Biol 1999; 44: 293–308
   PubMedGoogle Scholar
• Cideciyan A V, Jacobson S G, Kemp C M, Knighton R W, Nagel J H. Registration of high resolution images of the retina. SPIE Med Imaging VI: Image Process 1992; 1652: 310–322
   Google Scholar
• Weishaupt K R, Gomer C J, Dougherty T J. Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of a murine tumor. Cancer Res 1976; 36: 2326–2329
   PubMed Web of Science ®Google Scholar
• Henderson B W, Dougherty T J. How does photodynamic therapy work?. Photochem Photobiol 1992; 55: 145–157
   PubMed Web of Science ®Google Scholar
• Moan J, Peng Q, Evensen J F, Berg K, Western A, Rimington C. Photosensitizing efficiencies, tumor, and cellular uptake of different photosensitizing drugs relevant for photodynamic therapy of cancer. Photochem Photobiol 1987; 46: 713–721
   PubMed Web of Science ®Google Scholar
• Rosenthal I. Phthalocyanines as photosensitizers. Photochem Photobiol 1991; 53: 859–870
   PubMed Web of Science ®Google Scholar
• Fingar V H. Vascular effects of photodynamic therapy. J Clin Laser Med Surg 1996; 14: 323–328
   PubMedGoogle Scholar
• Michels S, Schmidt-Erfurth U. Sequence of early vascular events after photodynamic therapy. Invest Ophthalmol Vis Sci 2003; 44: 2147–2154
   PubMed Web of Science ®Google Scholar
• Schmidt-Erfurth U, Niemeyer M, Geitzenauer W, Michels S. Time course and morphology of vascular effects associated with photodynamic therapy. Ophthalmology 2005; 112: 2061–2069
   PubMed Web of Science ®Google Scholar
• Blinder K J, Bradley S, Bressler N M. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP Report 1. Am J Ophthalmol 2003; 136: 407–418
   PubMed Web of Science ®Google Scholar
• Van d e, Moore A, Sandhu S S, Talks S J. Correlation of optical coherence tomography and fundus fluorescein angiography following photodynamic therapy for choroidal neovascular membranes. Br J Ophthalmol 2006; 90: 304–306
   PubMedGoogle Scholar
• Midena E, Radin P P, Pilotto E, Ghirlando A, Convento E, Varano M. Fixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. A microperimetry study. Semin Ophthalmol 2004; 19: 55–61
   PubMedGoogle Scholar
• Palmowski A M, Allgayer R, Heinemann-Vernaleken B, Ruprescht K W. Influence of photodynamic therapy in choroidal neovascularization on focal retinal function assessed with the multifocal electroretinogram and perimetry. Ophthalmology 2002; 109: 1788–1792
   PubMed Web of Science ®Google Scholar